Viatris EV/EBIT VTRS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2021.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 159×; Jul 2026
5-year median: 34.3×
5-year range: 14.3× to 181×
Peer median: 20.3×

Viatris has no meaningful EV/EBIT today: it made an operating loss of $87.3M over the last twelve months.

It was last meaningful in Jul 2026, at 159×.

On the days it had one over the last 5 years, its median was 34.3×, from 14.3× in May 2023 to 181× in May 2026.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	159×	147×	181×
2025	153×	41.0×	153×
2024	44.2×	21.3×	45.8×
2023	20.9×	14.3×	20.9×
2022	18.2×	17.0×	85.2×
2021	80.8×	77.3×	82.3×

Against its peers

Companies in Healthcare nearest Viatris' size, closest first, today.

Company	EV/EBIT
VTRSViatris	n/m
THCTenet Healthcare	7.5×
STESTERIS	21.0×
ZBHZimmer Biomet	21.5×
MEDPMedpace	31.4×
INCYIncyte	10.1×
RVTYRevvity	46.0×
UTHRUnited Therapeutics	16.1×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
EXELExelixis	15.4×
Peer median	20.3×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Viatris

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.